Historical record - last NADAC effective date: 5/22/2019
Product Information
FLECAINIDE ACETATE 150 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.4993 per EA under NDC 00054001220. Its NADAC has been published 170 times since Aug 26, 2015.
FDA first approved this application on Jan 14, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the flecainide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054001220
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/22/2019
Active Ingredients
FLECAINIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA076278FDA Approved
1/14/2003
TE Code
AB
On Market Since
1/14/2003
Pharmacological Classes
Price Statistics
The NADAC for FLECAINIDE ACETATE 150 MG TAB has been published 170 times since Aug 26, 2015, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4993 per EA |
|---|---|
| All-time high | $0.8144 (Apr 13, 2016) |
| All-time low | $0.3917 (Apr 18, 2018) |
| Median price | $0.6500 |
| Average price | $0.6411 |
| Largest weekly change | -40.4% (Apr 18, 2018) |
| Weeks tracked | 170 |
| Tracking since | Aug 26, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-38.5%
Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLECAINIDE ACETATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLECAINIDE ACETATE 150 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.4993 per EA (NDC 00054001220), effective May 22, 2019.
How has the price of FLECAINIDE ACETATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for FLECAINIDE ACETATE 150 MG TAB has declined 38.5%. It has been tracked across 170 weekly CMS publications since Aug 26, 2015.
What are the highest and lowest recorded NADAC prices for FLECAINIDE ACETATE 150 MG TAB?
Since Aug 26, 2015, the NADAC for FLECAINIDE ACETATE 150 MG TAB has ranged from a low of $0.3917 (Apr 18, 2018) to a high of $0.8144 (Apr 13, 2016), with a median of $0.6500 per EA.
Are there cheaper alternatives to FLECAINIDE ACETATE 150 MG TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLECAINIDE ACETATE 150 MG TAB, is $0.2590 per EA — about 48% below FLECAINIDE ACETATE 150 MG TAB.
Who manufactures FLECAINIDE ACETATE 150 MG TAB?
FLECAINIDE ACETATE 150 MG TAB (NDC 00054001220) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.